I see the Company chugging along and pretty much d

I see the Company chugging along and pretty much doing what they said they would do........advance clinical trials, attempt to bring in new investors, advance their science, etc. This is an R&D company and despite being around awhile is still a new company with typical start up problems. While I did not like the 500 for 1 option it made sense given the share price might drop to .01 or worse. Most of the recent complaining makes little sense to me, management is working for peanuts and there will be no real payoff unless pps moves up. The delays are typical of the industry and therefore, expected.

Hopefully, communication will improve but I would rather have them spend their time on getting us marketable products with distribution centers and patent protections.

My comments are directed to those of us with skin in the game, not the irate negative people that hang around without any investment while pouting over their realized loses. Sorry fellas but do not take it out on the rest of us as your tirades are tiring and mistakenly characterize existing shareholders as losers............